Quidel specializes in a diverse range of diagnostic solutions aimed at enhancing healthcare outcomes. Their product offerings include the QuickVue® COVID-19 Test, designed for at-home use, which emphasizes speed and simplicity. Additionally, Quidel provides a comprehensive suite of laboratory solutions, including clinical chemistry and immunoassay products, cell culture supplies, and various testing systems such as the Ortho® Workstation Immunohematology Analyzer and the Solana® Molecular Testing Platform. These technologies are geared towards delivering fast, accurate, and reliable results across different healthcare settings, from home testing to clinical laboratories.

The company also focuses on point-of-care testing and molecular diagnostics, offering products like the Triage® System and the Lyra® Assays. Quidel's commitment to innovation is evident in their automated and semi-automated immunohematology testing solutions, which streamline laboratory processes and improve efficiency. Their technologies are designed to provide actionable diagnostic insights, supporting healthcare providers in achieving optimal patient outcomes. Overall, Quidel's extensive portfolio reflects their dedication to transforming diagnostic data into meaningful health information.

United States

QuidelOrtho develops and manufactures intelligent solutions that are transforming data into understanding and action for more people in more places every day, helping spot trends sooner, respond quicker and chart the course ahead with accuracy and confidence. Together, we are advancing diagnostics to power a healthier future.

Quidel

Company Details